An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition

In a highly unusual move, a U.S. Food and Drug Administration (FDA) committee voted against FDA staff’s own advice in a meeting on July 23 and 24, recommending that six peptides be added to a list that will allow certain specialty pharmacies to dispense them. Currently, those peptides are in a legal gray area. The committee voted against adding to the list one of the peptides being considered, emideltide.